Source: The Indian Express

Authorities say that the analysis is ongoing as is the drive, in accordance with the ICMR recommendation for prophylactic use of HCQ. VMC Health Officer Dr Devesh Patel says, “The debate around HCQ is founded in the side effects of long term use of the drug for treatment of rheumatoid arthritis and other illnesses.

The Vadodara administration has begun analysing the effects of the drug Hydroxychloroquine (HCQ) in containing the cases in the city. The Vadodara health department has prepared a report analysing its drive of administering HCQ since April, taking a sample of over one lakh residents who took a course of the anti-malarial drug as prophylactic.

Until Wednesday, the Vadodara Municipal Corporation (VMC) has administered the drug to 3.42 lakh persons, including health workers and other frontline staff. Each of these persons has or will have completed the entire course of the drug — 400mg twice a day for the first dose and 400 mg per week for a minimum of three weeks.

Of this, the administration has analysed a sample of over 1 lakh residents, who were mostly close contacts of positive persons and the effect of HCQ in containing the transmission of the virus. According to the analysis, of the 48,873 close contacts of positive patients who took one dose of HCQ, 102 turned Covid-19 positive and 12 succumbed to the infection whereas 48 of the 17,776 close contacts of positive patients who took two doses of HCQ turned positive and only one died. The study also states that of the 33,563 close contacts of patients who took three HCQ doses, 43 tested positive and one died.

Authorities say that the analysis is ongoing as is the drive, in accordance with the ICMR recommendation for prophylactic use of HCQ. VMC Health Officer Dr Devesh Patel says, “The debate around HCQ is founded in the side effects of long term use of the drug for treatment of rheumatoid arthritis and other illnesses… So far, HCQ has not been used as a prophylactic… To us, it has shown positive results. We have the numbers and not one person has complained of complications. The only side effect reported is mild gastritis, which is common with administering heavy medicines and can be effectively handled.”

Patel said the drug was administered to close contacts of positive patients in the cluster neighbourhoods of Nagarwada-Saiyedpura area of the old city, which was the city’s first red zone, with a population of around 5,000 persons, in the first week of April. The administration began its analysis in the first week of June.

The drug was also prescribed and promoted by the Baroda Muslim Doctors Association (BMDA), which has been a core partner of the administration to provide Covid-19 care and screening in minority-dominated areas. Dr Mohammad Hussain, president of BMDA, who also runs Faith Hospital in Panigate area of the city, has been continuously promoting the use of HCQ among the community even now.

Dr Hussain told this newspaper, “In Vadodara, it has shown positive results. We have been able to restrict cases in clusters. Nagarwada no longer has a huge number of cases. We haven’t seen any one developing side effects.”

Hussain said that the BMDA took lead in promoting HCQ in the initial red zone areas that were mostly in minority-dominated areas. “When the administration approached us, we prescribed HCQ and also created awareness about the need to consent to the course. The result has been fruitful. Even in my hospital, I have ensured that all doctors and employees take HCQ as they are in the frontline. Thankfully, none has contracted the virus yet,” Hussain said.

Dr Mohammad Hussain, president of BMDA, who also runs Faith Hospital

A senior doctor from Gujarat Medical Education Research Society (GMERS)-run Gotri Medical College, the biggest Covid-19 facility in the city that also caters to neighbouring districts, says, “Our residents and doctors are on rotational duty for seven days at a time. Almost all of them have completed at least two rounds… We haven’t seen our healthcare staff falling to the virus yet, barring a couple of cases where the source of infection could not be traced. Although HCQ, with or without Azithromycin and other supplements like zinc, will not help anyone who has tested positive, it definitely has an impact in preventive measures and reducing the complications.”

Officer on Special Duty Vinod Rao said that the administration had apprised the state government about its findings from the analysis so far.

“The task force of medical experts, including physicians and super specialists, have recommend and backed the drive to administer HCQ in cluster areas and high exposure cases. We have discussed the analysis and the results with the government.”

“The benefits seem to far outweigh the debate around its risks and it has certainly helped in implementing the preventive strategies planned for the city,” Rao said.

Officer on Special Duty Vinod Rao

On Wednesday, Vadodara’s Covid-19 tally stood at 2,338 with a current doubling rate of 25 days. The VMC, until Wednesday, declared 57 deaths after an audit according to ICMR guidelines.





Related:

India: HCQ beneficial as preventive drug: SMS doctors told ICMR

At 75% recovery rate, Rajasthan tops national average in curing COVID-19 patients

80% dip in infection risk for Indian health staff on HCQ: Study

Maharashtra: HCQ now a part of state government’s recommended treatment protocol

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Stark madness to ban ivermectin

Buried in the note is the real reason for making ivermectin inaccessible – the fear that persons taking it ‘may elect not to be vaccinated as part of the national Covid-19 vaccination program’. This is outrageous. When someone is infected with Covid, it is too late to bother with vaccination. They need early treatment. To deny it to coerce them into accepting a vaccine, one of whose side-effects is death, is immoral.

Read More »

Australia’s TGA Bans GPs from Prescribing Ivermectin

Australia’s medicine and therapeutic regulatory, the Therapeutic Good Administration (TGA) recently took the gloves off with Ivermectin, the economical anti-parasitic drug associated with at least 63 completed clinical trials involving SARS-CoV-2, the virus behind COVID-19. Now TGA formally places a national prohibition on off-label prescribing of ivermectin to all general practitioners. A comparable move as to what TGA did with hydroxychloroquine in 2020. Clearly further evidence of tightening encroachment of the critically important doctor-patient treatment relationship allowing consent to medical treatment using off-label medications. Of course, this isn’t occurring in a vacuum—it’s part of an unfolding, integrated and what have the signs of a coordinated and orchestrated government action to stop any and all treatments other than those the government declares acceptable.

Read More »